These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36015223)

  • 1. A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response.
    Xia M; Huang P; Tan M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Viral Protein 4-Based Trivalent Nanoparticle Vaccine Elicited High and Broad Immune Responses and Protective Immunity against the Predominant Rotaviruses.
    Xia M; Huang P; Vago F; Kawagishi T; Ding S; Greenberg HB; Jiang W; Tan M
    ACS Nano; 2024 Feb; 18(8):6673-6689. PubMed ID: 38353701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses.
    Xia M; Huang P; Jiang X; Tan M
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33419150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rotavirus NSP4 protein on the immune response and protection of the S
    Liu C; Huang P; Zhao D; Xia M; Zhong W; Jiang X; Tan M
    Vaccine; 2021 Jan; 39(2):263-271. PubMed ID: 33309483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineered Norovirus S
    Xia M; Huang P; Sun C; Han L; Vago FS; Li K; Zhong W; Jiang W; Klassen JS; Jiang X; Tan M
    ACS Nano; 2018 Nov; 12(11):10665-10682. PubMed ID: 30234973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
    Xia M; Huang P; Jiang X; Tan M
    Vaccine; 2019 Jul; 37(30):4103-4110. PubMed ID: 31201052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudovirus Nanoparticles Displaying
    Xia M; Huang P; Vago F; Jiang W; Tan M
    Vaccines (Basel); 2023 Oct; 11(11):. PubMed ID: 38005982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial.
    Groome MJ; Fairlie L; Morrison J; Fix A; Koen A; Masenya M; Jose L; Madhi SA; Page N; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
    Lancet Infect Dis; 2020 Jul; 20(7):851-863. PubMed ID: 32251641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioengineered pseudovirus nanoparticles displaying the HA1 antigens of influenza viruses for enhanced immunogenicity.
    Xia M; Hoq MR; Huang P; Jiang W; Jiang X; Tan M
    Nano Res; 2022; 15(5):4181-4190. PubMed ID: 35106126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.
    Groome MJ; Koen A; Fix A; Page N; Jose L; Madhi SA; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
    Lancet Infect Dis; 2017 Aug; 17(8):843-853. PubMed ID: 28483414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge.
    Xia M; López K; Vago FS; Huang P; Auguste DI; Jiang W; Auguste AJ; Tan M
    Biotechnol J; 2023 Oct; 18(10):e2300130. PubMed ID: 37300425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix
    Hensley C; Nyblade C; Zhou P; Parreño V; Ramesh A; Frazier A; Frazier M; Garrison S; Fantasia-Davis A; Cai R; Huang PW; Xia M; Tan M; Yuan L
    Vaccines (Basel); 2023 May; 11(5):. PubMed ID: 37243031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents.
    Roier S; Mangala Prasad V; McNeal MM; Lee KK; Petsch B; Rauch S
    NPJ Vaccines; 2023 Dec; 8(1):190. PubMed ID: 38129390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults.
    Fix AD; Harro C; McNeal M; Dally L; Flores J; Robertson G; Boslego JW; Cryz S
    Vaccine; 2015 Jul; 33(31):3766-72. PubMed ID: 26065919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate.
    Xue M; Yu L; Che Y; Lin H; Zeng Y; Fang M; Li T; Ge S; Xia N
    Vaccine; 2015 May; 33(22):2606-13. PubMed ID: 25882173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.
    Wen X; Cao D; Jones RW; Hoshino Y; Yuan L
    Hum Vaccin Immunother; 2015; 11(10):2483-9. PubMed ID: 26091081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of P[8], P[4], and P[6] VP8* genes of human rotaviruses globally reported during 1974 and 2017: possible implications for rotavirus vaccines in development.
    Velasquez DE; Jiang B
    Hum Vaccin Immunother; 2019; 15(12):3003-3008. PubMed ID: 31124743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycan Binding Specificity and Mechanism of Human and Porcine P[6]/P[19] Rotavirus VP8*s.
    Sun X; Li D; Qi J; Chai W; Wang L; Wang L; Peng R; Wang H; Zhang Q; Pang L; Kong X; Wang H; Jin M; Gao GF; Duan Z
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29720519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Group C Rotavirus VP8*s Recognize Type A Histo-Blood Group Antigens as Ligands.
    Sun X; Wang L; Qi J; Li D; Wang M; Cong X; Peng R; Chai W; Zhang Q; Wang H; Wen H; Gao GF; Tan M; Duan Z
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs.
    Ramesh A; Mao J; Lei S; Twitchell E; Shiraz A; Jiang X; Tan M; Yuan AL
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31698824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.